Medifast, Inc.
MED
$11.48
$0.000.00%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 316.93M | 346.10M | 385.79M | 429.70M | 480.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.93M | 346.10M | 385.79M | 429.70M | 480.45M |
| Cost of Revenue | 97.48M | 103.41M | 110.60M | 118.43M | 125.67M |
| Gross Profit | 219.45M | 242.70M | 275.19M | 311.27M | 354.78M |
| SG&A Expenses | 237.94M | 257.93M | 286.20M | 300.97M | 338.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 338.62M | 364.53M | 400.00M | 422.89M | 467.46M |
| Operating Income | -21.69M | -18.43M | -14.21M | 6.80M | 12.99M |
| Income Before Tax | -13.97M | -8.11M | -5.64M | 2.02M | 6.25M |
| Income Tax Expenses | 11.63M | 11.92M | 13.03M | 1.77M | 2.62M |
| Earnings from Continuing Operations | -25.60 | -20.02 | -18.67 | 0.25 | 3.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.60M | -20.02M | -18.67M | 248.00K | 3.64M |
| EBIT | -21.69M | -18.43M | -14.21M | 6.80M | 12.99M |
| EBITDA | -7.84M | -3.98M | 30.00K | 20.76M | 26.69M |
| EPS Basic | -2.33 | -1.82 | -1.70 | 0.02 | 0.33 |
| Normalized Basic EPS | -0.91 | -0.58 | -0.36 | 0.79 | 1.04 |
| EPS Diluted | -2.33 | -1.83 | -1.71 | 0.01 | 0.32 |
| Normalized Diluted EPS | -0.91 | -0.58 | -0.36 | 0.79 | 1.03 |
| Average Basic Shares Outstanding | 44.12M | 43.98M | 43.92M | 43.87M | 43.81M |
| Average Diluted Shares Outstanding | 44.12M | 44.05M | 43.99M | 43.98M | 43.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.66% | -0.44% | -1.04% | 78.63% | 5.39% |